Subtypes of Peripheral T‐cell Lymphoma
Must reads
References
23 Allogeneic Stem‐cell Transplantation
Introduction
Allogeneic Stem‐cell Transplantation for Relapsed and Refractory Disease (Focus on Nodal Hystotypes)
Allogeneic Stem‐cell Transplantation as Consolidation of First Remission
Allogeneic Stem‐cell Transplantation in Specific Subtypes
Future Directions
Must Reads
References
24 Emerging Immunotherapy Approaches in Peripheral T‐cell Lymphomas
Introduction
Monoclonal Antibody Therapy
Immunoconjugate‐Based Therapy for Peripheral T‐Cell Lymphoma
Cell‐Mediated or Cellular Immunotherapy in Peripheral T‐Cell Lymphoma
Challenges and Future Directions
Must Reads
References
25 Emerging New Small Molecules in Peripheral T‐cell Lymphomas
Introduction
Demethylating Agents
Janus‐associated Kinase–Signal Transducers and Activators of Transcription and Spleen Tyrosine Kinase Inhibitors
Phosphatidylinositol 3‐Kinase Inhibitors
Miscellaneous
Conclusion
Must Reads
References
10 Part V: Future Directions 26 The Value and Relevance of T‐cell Lymphoma Registries Introduction Population‐based Cancer Registries Retrospective Studies T‐cell Lymphoma Registries Future Directions Disclosures Must Reads References 27 Innovative Chemotherapy‐free Approaches for the Treatment of Peripheral T‐Cell Lymphoma Introduction Targeting the Peripheral T‐cell Lymphoma Epigenome Romidepsin Plus Pralatrexate Romidepsin Plus 5‐Azacytidine Romidepsin Plus Duvelisib Romidepsin Plus Lenalidomide Panobinostat and Bortezomib A Glance at the Future: Building on the Active Doublets Must Reads References 28 Global Collaborations Introduction The Global T‐cell Lymphoma Consortium Conclusion
11 Index
List of Tables
1 Chapter 2Table 2.1 Main nodal and extranodal mature T‐cell neoplasms with summary of t...
2 Chapter 3Table 3.1 Classes of histone deacetylase inhibitor (HDACi).Table 3.2 Single agents targeting the T‐cell lymphoma epigenome.Table 3.3 Combination agents targeting the T‐cell lymphoma epigenome.
3 Chapter 4Table 4.1 Mouse models of peripheral T‐cell lymphomas (PTCL)
4 Chapter 5Table 5.1 Major lymphoma subtypes by geographic region
5 Chapter 8Table 8.1 Peripheral T‐cell lymphoma not otherwise specified molecular subgroup...
6 Chapter 9Table 9.1 Characteristic of patients with angioimmunoblastic T‐cell lymphoma ...Table 9.2 Frequency of mutations of genes implicated in DNA methylation in an...
7 Chapter 10Table 10.1 Clinical features of anaplastic large‐cell lymphomas.Table 10.2 Pathological and molecular features of anaplastic large‐cell lymph...Table 10.3 Current treatment of anaplastic large‐cell lymphoma.Table 10.4 Future directions for treatment of anaplastic large‐cell lymphoma.
8 Chapter 11Table 11.1 Prospective clinical trials for aggressive adult T‐cell leukemia/l...Table 11.2 Meta‐analysis of interferon alpha plus zidovudine for adult T‐cell...
9 Chapter 12Table 12.1 Chemoradiotherapy regimens for stage IE/IIE nasal extranodal natur...
10 Chapter
